BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36760066)

  • 1. Establishment of a novel 70K Mac-2 binding protein antibody through screening of fucosylation-related antibodies.
    Masuda M; Asuka T; Terao N; Nishino S; Ikeda S; Takamatsu S; Kondo J; Miyoshi E
    J Biochem; 2023 May; 173(6):487-495. PubMed ID: 36760066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Mac-2BP secretion is mediated by its N-glycan binding to ERGIC-53.
    Chen Y; Hojo S; Matsumoto N; Yamamoto K
    Glycobiology; 2013 Jul; 23(7):904-16. PubMed ID: 23550150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
    Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
    Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis.
    Maekawa T; Kamada Y; Ebisutani Y; Ueda M; Hata T; Kawamoto K; Takamatsu S; Mizutani K; Shimomura M; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
    World J Gastroenterol; 2016 May; 22(17):4403-10. PubMed ID: 27158210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of mouse Mac-2 binding protein enzyme-linked immunosorbent assay and its application for mouse chronic liver disease models.
    Iwata A; Kamada Y; Ebisutani Y; Yamamoto A; Ueda Y; Arai H; Fujii H; Takamatsu S; Maruyama N; Maeda M; Takehara T; Miyoshi E
    Hepatol Res; 2017 Aug; 47(9):902-909. PubMed ID: 27615366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells.
    Shirure VS; Reynolds NM; Burdick MM
    PLoS One; 2012; 7(9):e44529. PubMed ID: 22970241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.
    Park YP; Choi SC; Kim JH; Song EY; Kim JW; Yoon DY; Yeom YI; Lim JS; Kim JW; Paik SG; Lee HG
    Int J Cancer; 2007 Feb; 120(4):813-20. PubMed ID: 17131321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas.
    Nonaka M; Ma BY; Imaeda H; Kawabe K; Kawasaki N; Hodohara K; Kawasaki N; Andoh A; Fujiyama Y; Kawasaki T
    J Biol Chem; 2011 Jun; 286(25):22403-13. PubMed ID: 21515679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
    Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
    Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of STAT3 as a negative regulator in Mac2- binding protein expression.
    Park YP; Kim JT; Yang Y; Lim JS; Yoon DY; Kim JW; Lee HG
    Korean J Lab Med; 2008 Jun; 28(3):230-8. PubMed ID: 18594176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
    Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
    Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
    Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
    Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the extracellular matrix-located Mac-2 binding protein as an interactor of the Wnt proteins.
    Pikkarainen T; Nurmi T; Sasaki T; Bergmann U; Vainio S
    Biochem Biophys Res Commun; 2017 Sep; 491(4):953-957. PubMed ID: 28756229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Mac-2BP by nerve growth factor is regulated by the PI3K/Akt/NF-kappaB-dependent pathway in the HEK293 cell line.
    Park YP; Choi SC; Kim BY; Kim JT; Song EY; Kang SH; Yoon DY; Paik SG; Kim KD; Kim JW; Lee HG
    BMB Rep; 2008 Nov; 41(11):784-9. PubMed ID: 19017490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.
    Kamada Y; Fujii H; Fujii H; Sawai Y; Doi Y; Uozumi N; Mizutani K; Akita M; Sato M; Kida S; Kinoshita N; Maruyama N; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    Proteomics Clin Appl; 2013 Oct; 7(9-10):648-56. PubMed ID: 23775887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
    Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH
    Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twin research shows glycan changes are more susceptible to environmental factors than their carrier glycoproteins.
    Asuka T; Kamada Y; Morishita K; Fukuoka T; Takamatsu S; Kondo J; Watanabe M; Sakai N; Hayakawa K; Miyoshi E;
    Glycoconj J; 2023 Apr; 40(2):191-198. PubMed ID: 36787035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
    Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
    J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.